Pancreatic Cancer Research

ResearcherXiamen UniversityActive in the last 2 years

Lin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6453-7996; OpenAlex author ID A5100633822. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells. Co-author DOI 10.1186/s12967-025-07164-0↗
  2. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets. Co-author DOI 10.1016/j.bbcan.2024.189183↗
  3. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition. Co-author DOI 10.1155/2019/8042489↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bingrong Chen · 1 shared paper, 2025 · strength 0.27
  2. Hao Wu · 1 shared paper, 2025 · strength 0.27
  3. Ziwen Liu · 1 shared paper, 2025 · strength 0.27
  4. Qiyao Zhang · 1 shared paper, 2025 · strength 0.27
  5. Bangbo Zhao · 1 shared paper, 2024 · strength 0.23
  6. Cheng Qin · 1 shared paper, 2024 · strength 0.23
  7. Yutong Zhao · 1 shared paper, 2024 · strength 0.23
  8. Weibin Wang · 1 shared paper, 2024 · strength 0.23
  9. Tianyu Li · 1 shared paper, 2024 · strength 0.23
  10. Zeru Li · 1 shared paper, 2024 · strength 0.23
  11. Zhixian Wu · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.